Two RCTs (n=45) were eligible for inclusion. Sample sizes per treatment group ranged from eight to 10 participants. Both RCTs reported group similarities at baseline and were both assumed to use intention-to-treat analysis. The remaining quality assessment items were addressed only by one or the other RCT.
There were no statistically significant differences in FEV1 and FVC between patients who received inspiratory muscle training and control groups. Individual study results were inconclusive for inspiratory muscle strength, but showed some improvement for inspiratory muscle endurance in the inspiratory muscle training group compared to sham group.
Exercise capacity outcomes of workload and exercise duration significantly increased in the high-intensity intervention group (80%), but not in the low-intensity group (one RCT). The second RCT found no significant changes in exercise capacity.
There were no significant changes in dyspnoea in the intervention or sham group (one RCT). Quality of life outcomes indicated significant improvement in the Hospital Anxiety and Depression Scale in the high-intensity intervention group; no significant changes were reported in the low-intensity intervention group or controls. Only one adverse event was reported in the inspiratory muscle training group.